Home Duke University Press
 QUICK SEARCH:   [advanced]


     
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents


First published on February 28, 2007
This version was published on April 1, 2007
Neuro Oncol 2007 9(2):135-144; DOI:10.1215/15228517-2006-038
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Detailed data
Right arrow All Versions of this Article:
9/2/135    most recent
15228517-2006-038v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (2)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vibhakar, R.
Right arrow Articles by Madan, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Duke University Press

Special Focus: Pediatric Neuro-Oncology

Dickkopf-1 is an epigenetically silenced candidate tumor suppressor gene in medulloblastoma1

Rajeev Vibhakar, Greg Foltz, Jae-geun Yoon, Lorie Field, Hwahyung Lee, Gi-yung Ryu, Jessica Pierson, Beverly Davidson and Anup Madan2

Departments of Pediatrics (R.V., J.P.), Neurosurgery (G.F., J.Y., L.F., H.L., G.R., A.M.), and Internal Medicine (B.D.), University of Iowa, Iowa City, IA 52242; Institute for Systems Biology, Seattle, WA 98103 (G.F., A.M.); USA

2 Address correspondence to Rajeev Vibhakar, M.D., Ph.D., Pediatric Hematology-Oncology, University of Iowa, Iowa City, IA 52242 (Rajeev-Vibhakar{at}uiowa.edu).

Medulloblastoma is a heterogeneous pediatric brain tumor with significant therapy-related morbidity, its five-year survival rates ranging from 30% to 70%. Improvement in diagnosis and therapy requires better understanding of medulloblastoma pathology. We used whole-genome microarray analysis to identify putative tumor suppressor genes silenced by epigenetic mechanisms in medulloblastoma. This analysis yielded 714 up-regulated genes in immortalized medulloblastoma cell line D283 on treatment with histone deacetylase (HDAC) inhibitor trichostatin A (TSA). Dickkopf-1 (DKK1), a Wnt antagonist, was found to be up-regulated on HDAC inhibition. We examined DKK1 expression in primary medulloblastoma cells and patient samples by reverse transcriptase PCR and found it to be significantly down-regulated relative to normal cerebellum. Transfection of a DKK1 gene construct into D283 cell lines suppressed medulloblastoma tumor growth in colony focus assays by 60% (P < 0.001). In addition, adenoviral vector-mediated expression of DKK1 in medulloblastoma cells increased apoptosis fourfold (P < 0.001). These data reveal that inappropriate histone modifications might deregulate DKK1 expression in medulloblastoma tumorigenesis and block its tumor-suppressive activity.

Key Words: Dickkopf-1 • epigenetic • histone deacetylation • medulloblastoma • tumor suppressor




This article has been cited by other articles:


Home page
ReproductionHome page
S. Peng, J. Li, C. Miao, L. Jia, Z. Hu, P. Zhao, J. Li, Y. Zhang, Q. Chen, and E. Duan
Dickkopf-1 secreted by decidual cells promotes trophoblast cell invasion during murine placentation
Reproduction, March 1, 2008; 135(3): 367 - 375.
[Abstract] [Full Text] [PDF]


Home page
Neuro OncolHome page
J. A. Anderton, J. C. Lindsey, M. E. Lusher, R. J. Gilbertson, S. Bailey, D. W. Ellison, and S. C. Clifford
Global analysis of the medulloblastoma epigenome identifies disease-subgroup-specific inactivation of COL1A2
Neuro-oncol, January 1, 2008; 10(6): 981 - 994.
[Abstract] [Full Text] [PDF]


Home page
Neuro OncolHome page
J. M. de Bont, R. J. Packer, E. M. Michiels, M. L. d. Boer, and R. Pieters
Biological background of pediatric medulloblastoma and ependymoma: A review from a translational research perspective
Neuro-oncol, January 1, 2008; 10(6): 1040 - 1060.
[Abstract] [Full Text] [PDF]




  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents


Copyright 2007 by Society for Neuro-Oncology